Arvinas (ARVN) Accumulated Expenses (2017 - 2022)
Arvinas' (ARVN) quarterly Accumulated Expenses came in at $30.2 million in Q1 2022, up 953.63% year-on-year from $2.9 million in Q1 2021, and up 30.74% quarter-over-quarter from $23.1 million in Q4 2021.
Arvinas (ARVN) Accumulated Expenses (2017 - 2022) Analysis & Trends
Arvinas' Accumulated Expenses history runs 6 years deep, the most recent figure standing at $30.2 million for Q1 2022.
- On a quarterly basis, Accumulated Expenses rose 953.63% year-over-year to $30.2 million in Q1 2022; TTM through Mar 2022 was $30.2 million, a 953.63% increase from a year earlier, with the FY2021 full-year figure at $23.1 million, up 22.22% from the prior year.
- Accumulated Expenses rose to $30.2 million in Q1 2022 per ARVN's latest filing, from $23.1 million in the prior quarter.
- Across five years, Accumulated Expenses topped out at $30.2 million in Q1 2022 and bottomed at $1.7 million in Q1 2019.
- The 5-year median for Accumulated Expenses is $6.8 million (2020), against an average of $9.8 million.
- Across the five-year window, Accumulated Expenses plunged 57.75% in 2021 and soared 953.63% in 2022, its largest moves.
- Year by year, Accumulated Expenses stood at $4.0 million in 2018, then soared by 90.01% to $7.6 million in 2019, then jumped by 148.59% to $18.9 million in 2020, then grew by 22.22% to $23.1 million in 2021, then jumped by 30.74% to $30.2 million in 2022.
- Per Business Quant, the three latest ARVN Accumulated Expenses figures stand at $30.2 million (Q1 2022), $23.1 million (Q4 2021), and $13.8 million (Q3 2021).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Arvinas | 519.68 Mn | -95.22 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2022 | 30.20 Mn |
| Dec 31, 2021 | 23.10 Mn |
| Sep 30, 2021 | 13.77 Mn |
| Jun 30, 2021 | 13.47 Mn |
| Mar 31, 2021 | 2.87 Mn |
| Dec 31, 2020 | 18.90 Mn |
| Sep 30, 2020 | 12.14 Mn |
| Jun 30, 2020 | 2.98 Mn |
| Mar 31, 2020 | 6.78 Mn |
| Dec 31, 2019 | 7.60 Mn |
| Sep 30, 2019 | 3.68 Mn |
| Jun 30, 2019 | 4.00 Mn |
| Mar 31, 2019 | 1.74 Mn |
| Dec 31, 2018 | 4.00 Mn |
| Sep 30, 2018 | 1.78 Mn |
| Dec 31, 2017 | 3.55 Mn |